ICN acquires Siemens' dosimetry service:
This article was originally published in Clinica
ICN Pharmaceuticals has acquired Siemens' dosimetry service business division for an undisclosed amount, following US regulatory clearance. ICN says the purchase will allow it to expand its radiation detection service from the US into international markets. The dosimetry service, which is part of Siemens Medical Systems, had worldwide revenues of $9.3 million in fiscal 1995. Global sales for dosimetry services were around $200 million in 1994.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.